Trials / Completed
CompletedNCT00609102
Antioxidant Treatment of Type 2 Diabetes
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | one capsule BID |
| DRUG | n-aceylcysteine | 450 mgm BID |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2008-02-06
- Last updated
- 2014-12-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00609102. Inclusion in this directory is not an endorsement.